Agilent Technologies, Inc. A
Verdict: Sell. Fair value $133 against a price of $138 on 5 Jan 2026, 4% below the price.
In plain words
The case for: Wide competitive moat provides durability. Market leadership enables pricing power. Industry tailwinds with growing market.
The case against: In 2024, Revenue declined by 4.7% ($6.83B to $6.51B) while Net Income increased by 4.0% ($1.24B to.... Net Margins expanded to 19.8% in 2024 despite sales drop, then compressed to 18.7% in 2025 as sales.... Critical forensic data (Operating Cash Flow, Total Assets, Inventory, Receivables) was not....
Main risks
- Long-term revenue stagnation (3-year CAGR is only 0.48% despite recent bump)
- Extremely high Put/Call Open Interest Ratio (8.84) suggests strong bearish sentiment or hedging
- Critical Balance Sheet data (Assets, Equity, Debt) missing, preventing solvency and return on capital analysis
- In 2024, Revenue declined by 4.7% ($6.83B to $6.51B) while Net Income increased by 4.0% ($1.24B to...
- Critical forensic data (Operating Cash Flow, Total Assets, Inventory, Receivables) was not...
- In 2024, Revenue declined by 4.7% ($6.83B to $6.51B) while Net Income increased by 4.0% ($1.24B to $1.29B). This inverse relationship suggests earnings were supported by cost-cutting, non-operating items, or accruals rather than organic growth.